| Product name | Rta |
| Appearance | White powder |
| Purity | 99% |
| Storage | Keep in a cool, dry, dark location in a tightly sealed container or cylinder. |
| Shelf Life | 24 Months |
Application:
Novel weight loss peptides were approved by the FDA for weight loss in late 2014. It's a newer class of drugs better known
for its ability to improve blood sugar control. These medications were actually designed to treat type II diabetes,
but some have also been FDA approved to treat weight loss. The Multi-agonists we work with are called Sema
& Tz.
Tz is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and
glucagon-like peptide-1 receptor. It showed glucose control and weight loss in patients with type 2 diabetes mellitus (T2DM).
It can be used for the research of obesity.
Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details,
please refer to the manual:Handling and Storage of Synthetic Peptides.
Rta is a triple glucagon, GIP, and GLP receptor agonist. Rta showed glucose control and weight loss in patients
with type 2 diabetes mellitus (T2DM).
What Is Rta?
Rta (LY-3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide
receptor (GIPR), and glucagon-like peptide-1 receptor.Retatrutide can be used for the research of obesity.
Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details,
please refer to the manual:Handling and Storage of Synthetic Peptides.
For Research Purpose Only. Purchasing objects are required to be companies and labs, not for personal use.
